SUCCESSFUL PRESCRIPTION TRIAL A GAME CHANGER FOR THE DUBBO ELECTORATE

Residents of the Dubbo electorate have been able to receive treatment for a range of conditions at their local pharmacy, under landmark reforms by the former Liberal and Nationals Government.

The 12-month trial began in November 2022, increasing the range of vaccinations that could be administered by a pharmacy, and allowing them to prescribe medication for Urinary Tract Infections (UTI) and the pill.

Member for the Dubbo electorate, Dugald Saunders said the reforms have been a game changer for the regions, making healthcare more accessible for the community and easing the burden on local hospitals and GP’s.

“This reform has been a huge success and completely transformational for healthcare in the Dubbo electorate, particularly for women,” Mr Saunders said.

“Local pharmacies play a crucial role in our communities and by empowering pharmacists to provide access to healthcare previously only available with a prescription has been revolutionary.

“With pharmacies now able to prescribe medication for UTIs and the pill, as well as expanding the range of vaccinations approved for administration by a pharmacist, we have alleviated some of the pressure on local doctors and made it easier for the community to access the health care they need.” 

“The NSW Coalition is committed to delivering tangible outcomes that makes people’s lives better, and this just goes to show how good ideas implemented into sound policy can make a real difference.”

More than 5000 women have been able to access UTI treatment over the counter since the trial began and 60 per cent of pharmacies across New South Wales are now participating.

Narromine Pharmacist, Felicity Roberts, said that the trial has made a real difference to healthcare particularly in western NSW.

“This trial has certainly been successful, and we’ve seen that locally as it frees up appointments for GP’s to see those who need more emergency and critical care.”

Leave a Comment

Your email address will not be published.

Scroll to Top